180 related articles for article (PubMed ID: 18833159)
1. [The combined treatment of colorectal cancer with liver metastases].
Patiutko IuI; Poliakov AN; Sagaĭdak IV; Kotel'nikov AG
Khirurgiia (Mosk); 2008; (7):20-3. PubMed ID: 18833159
[TBL] [Abstract][Full Text] [Related]
2. Multicentre study of perioperative
Allard MA; Nishioka Y; Beghdadi N; Imai K; Gelli M; Yamashita S; Kitano Y; Kokudo T; Yamashita YI; Sa Cunha A; Vibert E; Elias D; Cherqui D; Goere D; Adam R; Baba H; Hasegawa K
BJS Open; 2019 Oct; 3(5):678-686. PubMed ID: 31592094
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
[TBL] [Abstract][Full Text] [Related]
4. [Surgical treatment of hepatic metastases of colorectal neoplasms].
Landi E
G Chir; 2004 Oct; 25(10):317-23. PubMed ID: 15756953
[No Abstract] [Full Text] [Related]
5. In defense of hepatic arterial infusion for hepatic metastases of colorectal cancer.
Kemeny N
J Natl Compr Canc Netw; 2010 May; 8(5):507-9. PubMed ID: 20495081
[No Abstract] [Full Text] [Related]
6. [Advanced hepatic resection for malignancy].
Patiutko IuI; Pylev AL; Sagaĭdak IV; Kotel'nikov AG
Khirurgiia (Mosk); 2009; (2):16-22. PubMed ID: 19365329
[TBL] [Abstract][Full Text] [Related]
7. [HEMIHEPATECTOMY FOR RESECTABLE HEPATIC METASTASIS FROM COLORECTAL CANCER WITH POOR PROGNOSIS].
Patyutko YI; Kotelnikov AG; Mamontov KG; Podluzhny DV; Ponomarenko AA
Vopr Onkol; 2015; 61(3):439-47. PubMed ID: 26242159
[TBL] [Abstract][Full Text] [Related]
8. [Colorectal carcinoma].
Schulthess G; Kolyvanos Naumann U; Käser L; Vetter W
Praxis (Bern 1994); 2005 Nov; 94(44):1705-11; quiz 1712. PubMed ID: 16309014
[No Abstract] [Full Text] [Related]
9. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases.
Goéré D; Deshaies I; de Baere T; Boige V; Malka D; Dumont F; Dromain C; Ducreux M; Elias D
Ann Surg; 2010 Apr; 251(4):686-91. PubMed ID: 20224373
[TBL] [Abstract][Full Text] [Related]
10. R1 resection for aggressive or advanced colorectal liver metastases is justified in combination with effective prehepatectomy chemotherapy.
Tanaka K; Nojiri K; Kumamoto T; Takeda K; Endo I
Eur J Surg Oncol; 2011 Apr; 37(4):336-43. PubMed ID: 21277151
[TBL] [Abstract][Full Text] [Related]
11. [Treatment efficacy of surgical management for liver metastasis from colorectal cancer--a report of 198 cases].
Zhang ZG; Song C; Wang H
Ai Zheng; 2006 May; 25(5):596-8. PubMed ID: 16687081
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.
Boxberger F; Albrecht H; Konturek PC; Reulbach U; Maennlein G; Meyer T; Hohenberger W; Hahn EG; Wein A
Med Sci Monit; 2010 Feb; 16(2):CR49-55. PubMed ID: 20110914
[TBL] [Abstract][Full Text] [Related]
13. Place of hepatic intra-arterial chemotherapy in the treatment of colorectal liver metastases.
Allard MA; Malka D
J Visc Surg; 2014 Apr; 151 Suppl 1():S21-4. PubMed ID: 24636278
[TBL] [Abstract][Full Text] [Related]
14. Randomized phase II study of 5-fluorouracil hepatic arterial infusion with or without antineoplastons as an adjuvant therapy after hepatectomy for liver metastases from colorectal cancer.
Ogata Y; Matono K; Tsuda H; Ushijima M; Uchida S; Akagi Y; Shirouzu K
PLoS One; 2015; 10(3):e0120064. PubMed ID: 25790229
[TBL] [Abstract][Full Text] [Related]
15. [Combined treatment of inoperable liver metastases from colorectal cancer].
Milandri C; Calzolari F; Giampalma E; Vagliasindi A; Bertagni A; Ridolfi L; Passardi A; Ridolfi R; Golfieri R; Verdecchia GM
Tumori; 2003; 89(4 Suppl):112-4. PubMed ID: 12903565
[TBL] [Abstract][Full Text] [Related]
16. [Switching to direct intrahepatic arterial infusion of 5-FU after a progression of liver metastases from colorectal carcinoma treated with systemic infusion of FOLFOX].
Kikuoka S; Miura T; Takeuchi I; Miura T; Akamatsu N; Ishida F; Ozawa F; Moriguchi M
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2036-8. PubMed ID: 20037315
[TBL] [Abstract][Full Text] [Related]
17. Unresectable liver metastases from colorectal cancer and hepatic arterial infusion chemotherapy: how, when and to whom?
Viúdez A; Rodríguez J; Gil-Bazo I
Cardiovasc Intervent Radiol; 2009 May; 32(3):603-4. PubMed ID: 19194743
[No Abstract] [Full Text] [Related]
18. Evaluation of aggressively treated patients with unresectable multiple liver metastases from colorectal cancer.
Miyanari N; Mori T; Takahashi K; Yasuno M
Dis Colon Rectum; 2002 Nov; 45(11):1503-9. PubMed ID: 12432299
[TBL] [Abstract][Full Text] [Related]
19. [Adjuvant chemotherapy with FOLFOX4 regimen after curative resection of liver metastases from colorectal cancer].
Ohnishi T; Kanoh T; Tono T; Danno K; Watanabe A; Nakamura H; Tsukao Y; Inatome J; Kim T; Kagara N; Taniguchi H; Kimura Y; Nakano Y; Monden T; Imaoka S
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2554-6. PubMed ID: 21224637
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases.
Andreou A; Kopetz S; Maru DM; Chen SS; Zimmitti G; Brouquet A; Shindoh J; Curley SA; Garrett C; Overman MJ; Aloia TA; Vauthey JN
Ann Surg; 2012 Oct; 256(4):642-50. PubMed ID: 22968062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]